The Chicago Entrepreneur

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post For the fun of it: An Open House for my Spring 2025 Classes
Next post For the fun of it: An Open House for my Spring 2025 Classes